natgillin/translations-raw huggingface dataset:
Sticky eyes
Ljepljive oči
Stiff arms or legs
Ukočenost ruku ili nogu
Stiff joints, rib pain
ukočeni zglobovi, bol u rebrima
Still’s Disease
Stillova bolest
Still’s Disease (AOSD and SJIA)
Stillova bolest (SBOD i SJIA)
Still’s Disease (AOSD and SJIA)
Stillova bolest (SBOD i SJLA)
Still’s disease including AOSD and SJIA is an inflammatory disease that can cause pain, swelling and inflammation of one or more joints, as well as rash and fever.
Stillova bolest, uključujući SBOD i SJIA, je upalna bolest koja može uzrokovati bol, oticanje i upalu jednog ili više zglobova, kao i osip i vrućicu.
Still’s Disease SJIA
Stillova bolest SJIA
Still’s disease, including adult-onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (SJIA), rare diseases causing inflammation of joints as well as rash and fever.
Stillove bolesti, uključujući Stillovu bolest odrasle osobe (AOSD) i sistemski juvenilni idiopatski artritis (SJIA), rijetke bolesti koje uzrokuju upalu zglobova te osip i groznicu.
STIMULANTS
STIMULANSI
stimulating
nižene vrijednosti
Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra-fallopian transfer (ZIFT).
Stimulacija razvoja većeg broja folikula u bolesnica kod kojih se stimulira superovulacija za metode medicinski potpomognute oplodnje kao što su in vitro umjetna oplodnja (IVF), transfer gamete u jajovod (gamete intra-fallopian transfer - GIFT) i transfer zigote u jajovod (zygote intra-fallopian transfer - ZIFT).
Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and zygote intra-fallopian transfer.
Stimulacija razvoja većeg broja folikula u žena kod kojih se stimulira superovulacija za metode medicinski potpomognute oplodnje kao što su in vitro umjetna oplodnja (IVF), transfer gamete u jajovod (gamete intra-fallopian transfer - GIFT) i transfer zigote u jajovod (zygote intra- fallopian transfer - ZIFT).
Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and zygote intra-fallopian transfer.
Stimulacija razvoja većeg broja folikula u žena u kojih se stimulira superovulacija zbog medicinski potpomognute oplodnje (MPO) kao što su oplodnja in vitro (IVF), unošenje gamete u jajovod i unošenje zigote u jajovod.
Stimulation of the AT1 receptor is responsible for pathologic effects of angiotensin II in the kidney and other organs associated with angiotensin II such as vasoconstriction, retention of sodium and water, increased aldosterone synthesis and organ remodeling.
Stimulacija receptora AT1 odgovorna je za patološke učinke angiotenzina II u bubregu i drugim organima povezanim s angiotenzinom II kao što su vazokonstrikcija, retencija natrija i vode, povećana sinteza aldosterona i remodeliranje organa.
Stinging or swelling of the skin at the site of injection may also occur.
Mogu se pojaviti i bockanje ili oteklinu kože na mjestu injekcije.
Stir and drink immediately.
Promućkajte i odmah popijte
Stir the tablet until it has dispersed into the water.
Miješajte tabletu dok se ne rastopi u vodi.
Stir the water until the tablet breaks up into very small pieces - the tablet will not completely dissolve.
Promiješajte vodu dok se tableta ne raspadne u vrlo male dijelove – tableta se neće u potpunosti otopiti.
Stir to make sure there is no drug residue remaining in the container (illustration e).
Pomiješajte kako biste se uvjerili da nema ostataka lijeka u posudi (ilustracija e).
Stir until content in the stock suspension container is visibly homogeneous.
Miješati sadržaj u spremniku dok ne postane vidljivo homogen.
Stir until the tablet breaks up (the mixture will not be clear) then drink the mixture straight away or within 30 minutes.
Miješajte dok se tableta ne razgradi (mješavina neće biti bistra), a zatim mješavinu popijte odmah ili unutar 30 minuta.
Stir until the tablet(s) dissolve completely.
Miješajte dok se tableta(e) potpuno ne otopi.
Stir with a spoon until the tablets have completely dissolved.
Miješajte žlicom sve dok se tableta potpuno ne otopi.
Stir with a spoon until the tablets have completely dissolved.
Miješajte žlicom sve dok se tablete potpuno ne otope.
Stir with the small spoon or clean utensil until the tablets dissolve.
Miješajte malom žlicom ili čistim priborom za miješanje sve dok se tablete ne otope.
Stiripentol binds extensively to circulating plasma proteins (about 99%).
Stiripentol se opsežno veže za cirkulirajuće proteine plazme (oko 99%).
Stiripentol dosage escalation should be gradual, starting with 20mg/kg/day for 1 week, then 30mg/kg/day for 1 week.
Povećanje doze stiripentola treba biti postupno, počevši s 20mg/kg dnevno tijekom prvog tjedna, a potom 30mg/kg/dan tijekom drugog tjedna.
Stiripentol enhances the central depressant effect of chlorpromazine.
Stiripentol pojačava centralni depresivni učinak klorpromazina.
Stiripentol is not recommended for use in patients with impaired hepatic and/or renal function (see section 4.4).
Stiripentol se ne preporučuje za primjenu u bolesnika soštećenjem jetrene i/ili bubrežne funkcije. (vidjeti dio 4.4).
Stiripentol is quickly absorbed, with a time to peak plasma concentration of about 1.5 hours.
Stiripentol se brzo apsorbira, i za 1,5 sat dostiže najvišu razinu koncentracije u plazmi.
Stiripentol may cause dizziness and ataxia that may affect ability to drive and use machines and patients should not drive or use machinery whilst on stiripentol therapy.
Stiripentol može uzrokovati omaglicu i ataksiju koji mogu utjecati na sposobnost upravljanja vozilima i rada sa strojevima te bolesnici na terapiji stiripentolom ne bi trebali upravljati vozilima i raditi na strojevima.
Stiripentol may cause dizziness and ataxia that may affect ability to drive and use machines and patients should not drive or use machinery whilst on stiripentol therapy.
Stiripentol može uzrokovati omaglicu i ataksiju koji mogu utjecati na sposobnost upravljanja vozilima i rada sa strojevima te bolesnici na terapiji stiripentolom ne bi trebali upravljati vozilima i raditi sa strojevima.
Stiripentol must always be taken with food as it degrades rapidly in an acidic environment (e.g. exposure to gastric acid in an empty stomach).
Stiripentol se uvijek mora uzimati s hranom s obzirom da se brzo razlaže u kiselom okolišu ( kao što je izloženost želučanoj kiselini u praznom želucu).
Stiripentol must always be taken with food as it degrades rapidly in an acidic environment (e.g. exposure to gastric acid in an empty stomach).
Stiripentol se uvijek mora uzimati s hranom s obzirom da se brzo razlaže u kiselom okolišu (kao što je izloženost želučanoj kiselini u praznom želucu).
Stiripentol should not be taken with milk or dairy products (yoghurt, soft cream cheese, etc.), carbonated drinks, fruit juice or food and drinks that contain caffeine or theophylline.
Stiripentol ne treba uzimati s mlijekom ili mliječnim proizvodima ( jogurtom, mekim sirom itd.), gaziranim napitcima, voćnim sokovima ili hranom i napitcima koji sadrže kofein ili teofilin.
Stiripentol should not be taken with milk or dairy products (yoghurt, soft cream cheese, etc.), carbonated drinks, fruit juice or food and drinks that contain caffeine or theophylline.
Stiripentol ne treba uzimati s mlijekom ili mliječnim proizvodima (jogurtom, mekim sirom itd.), gaziranim napitcima, voćnim sokovima ili hranom i napitcima koji sadrže kofein ili teofilin.
Stivarga 40 mg film-coated tablets.
Stivarga 40 mg filmom obložene tablete
Stivarga 40 mg tablets are available in packs containing one bottle of 28 tablets and in a pack comprising 3 bottles, each containing 28 tablets.
Stivarga 40 mg tablete dostupne su u pakiranjima koja sadrže jednu bočicu s 28 tableta te u pakiranju s 3 bočice od kojih svaka sadrži 28 tableta.
Stivarga 40 mg tablets are light pink and oval, marked with “BAYER” on one side and “40” on the other side.
Stivarga 40 mg tablete svijetlo su ružičaste boje, ovalne, s oznakom “BAYER” na jednoj strani i “40” na drugoj.
Stivarga can cause severe bleeding in the digestive system such as stomach, throat, rectum or intestine, or in the lungs, kidneys, mouth, vagina and/or brain.
Stivarga može prouzročiti jako krvarenje u probavnom sustavu, na primjer, želucu, grlu, završnom, debelom ili tankom crijevu, ili u plućima, bubrezima, ustima, rodnici i/ili mozgu.
Stivarga had been shown to delay the worsening of the disease in these patients and its side effects are manageable.
Dokazano je kako Stivarga odgađa pogoršanje bolesti kod ovih bolesnika te je moguće kontrolirati nuspojave.
Stivarga has been associated with an increased incidence of electrolyte abnormalities (including hypophosphatemia, hypocalcaemia, hyponatraemia and hypokalaemia) and metabolic abnormalities (including increases in thyroid stimulating hormone, lipase and amylase).
Primjena lijeka Stivarga povezuje se s povećanom incidencijom poremećaja elektrolita (uključujući hipofosfatemiju, hipokalcemiju, hiponatremiju i hipokalemiju) i metaboličkih poremećaja (uključujući povećanje hormona koji stimulira štitnjaču, lipaza i amilaza).
Stivarga has been associated with an increased incidence of haemorrhagic events, some of which were fatal (see section 4.8).
Primjena lijeka Stivarga se povezuje s povećanom incidencijom krvarenja, u nekim slučajevima i sa smrtnim ishodom (vidjeti dio 4.8).
Stivarga is an anticancer medicine that contains the active substance regorafenib.
Stivarga je lijek protiv raka koji sadrži djelatnu tvar regorafenib.
Stivarga is available as tablets (40 mg).
Lijek Stivarga je dostupan u tabletama (40 mg).
Stivarga is indicated for the treatment of adult patients with
Stivarga je indicirana za liječenje odraslih bolesnika:
Stivarga is used in patients who have already been treated with, or who cannot be given, other available treatments.
Stivarga se koristi za liječenje bolesnika koji su prethodno liječeni ili im se ne mogu dati druge dostupne terapije.
Stivarga is used to treat: colon or rectal cancer that has spread to other parts of the body in adult patients who have received other treatments or cannot be treated with other medicines (fluoropyrimidine-based chemotherapy, an anti-VEGF therapy and an anti-EGFR therapy). gastrointestinal stromal tumors (GIST), a type of cancer of the stomach and bowel, that has spread to other parts of the body or is not amenable to surgery, in adult patients who have been previously treated with other anticancer medicines (imatinib and sunitinib).
Stivarga se primjenjuje za liječenje: raka debelog ili završnog dijela debelog crijeva koji se proširio na druge dijelove tijela u odraslih bolesnika nakon što su primili druga liječenja ili se ne mogu liječiti drugim lijekovima (kemoterapijom na bazi fluoropirimidina, anti-VEGF terapijom i anti-EGFR terapijom). gastrointestinalnih stromalnih tumora (GIST), vrste raka želuca i crijeva, koji se proširio na druge dijelove tijela ili se ne može kirurški ukloniti, u odraslih bolesnika prethodno liječenih drugim antitumorskim lijekovima (imatinibom i sunitinibom).
Stivarga plus BSC§ (N=132)
Stivarga uz najbolju potpornu njegu (N=132)
Stivarga plus BSC§ (N=133)
Stivarga uz najbolju potpornu njegu (N=133)
Stivarga plus BSC§ (N=136)
Stivarga uz najbolju potpornu njegu (N=136)
Stivarga plus BSC§ (N=500)
Stivarga uz najbolju potpornu njegu (N=500)
Stivarga plus BSC§ (N=505)
Stivarga uz najbolju potpornu njegu (N=505)
Stivarga should be permanently discontinued if there is no resolution.
Ako nema nestanka promjena, primjenu lijeka Stivarga mora se trajno prekinuti.
Stockley Park Uxbridge UB11 1DB
Celgene Europe Ltd 1 Longwalk Road Stockley Park Uxbridge UB11 1DB
STOCRIN 100 mg capsules
STOCRIN 100 mg kapsule
STOCRIN 100 mg hard capsules
STOCRIN 100 mg tvrde kapsule
Stocrin 100 mg hard capsules are supplied in bottles of 30 capsules.
Stocrin 100 mg tvrde kapsule dostupne su u boci sa 30 kapsula.
Stocrin 100 mg hard capsules efavirenz
Stocrin 100 mg tvrde kapsule efavirenz
STOCRIN 100 mg hard capsules White, printed with “3807”.
STOCRIN 100 mg tvrde kapsule Bijela, s otisnutom oznakom "3807".
STOCRIN 200 mg capsules
STOCRIN 200 mg kapsule
Stocrin 200 mg capsules are supplied in bottles of 90 capsules and in packs containing 42 x 1 capsules in aluminium perforated unit dose blisters.
Stocrin 200 mg kapsule dostupne su u boci sa 90 kapsula te u pakiranju sa 42 x 1 kapsulom u aluminijskim perforiranim blisterima djeljivima na jedinične doze.
STOCRIN 200 mg capsules efavirenz
STOCRIN 200 mg kapsule efavirenz
Stocrin 200 mg film-coated tablets efavirenz
Stocrin 200 mg filmom obložene tablete efavirenz
STOCRIN 200 mg hard capsules
STOCRIN 200 mg tvrde kapsule
STOCRIN 200 mg hard capsules Dark yellow, printed with “3809”.
STOCRIN 200 mg tvrde kapsule Tamnožuta, s otisnutom oznakom "3809".
STOCRIN 200 mg hard capsules efavirenz
STOCRIN 200 mg tvrde kapsule efavirenz
STOCRIN 200 mg hard capsules For bottles: 3 years.
STOCRIN 200 mg tvrde kapsule Za boce: 3 godine
STOCRIN 200 mg tablets
STOCRIN 200 mg tablete
STOCRIN 30 mg/ml oral solution efavirenz
STOCRIN 30 mg/ml oralna otopina efavirenz
STOCRIN 50 mg capsules
STOCRIN 50 mg kapsule
Stocrin 50 mg film-coated tablets efavirenz
Stocrin 50 mg filmom obložene tablete efavirenz
STOCRIN 50 mg hard capsules
STOCRIN 50 mg tvrde kapsule
Stocrin 50 mg hard capsules are supplied in bottles of 30 capsules.
Stocrin 50 mg tvrde kapsule dostupne su u boci sa 30 kapsula.
STOCRIN 50 mg hard capsules efavirenz
STOCRIN 50 mg tvrde kapsule efavirenz
STOCRIN 50 mg hard capsules STOCRIN 100 mg hard capsules STOCRIN 200 mg hard capsules
STOCRIN 50 mg tvrde kapsule STOCRIN 100 mg tvrde kapsule STOCRIN 200 mg tvrde kapsule
STOCRIN 50 mg tablets
STOCRIN 50 mg tablete
Stocrin 50 mg, 200 mg and 600 mg film-coated tablets are available.
dostupne su Stocrin 50 mg, 200 mg i 600 mg filmom obložene tablete
Stocrin 600 mg film-coated tablets efavirenz
Stocrin 600 mg filmom obložene tablete efavirenz
Stocrin does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Stocrin ne liječi infekciju HIV-om ili AIDS, no može odgoditi oštećenje imunosnog sustava i razvoj infekcija i bolesti povezanih s AIDS-om.
Stocrin Dose (mg)
Stocrin Doza (mg)
Stocrin Dose (mg)*
Stocrin Doza (mg)
Stocrin has also been studied in 57 children aged between three and 16 years, in combination with nelfinavir and other antiviral medicines.
Stocrin je također ispitan u 57 djece u dobi od tri do 16 godina u kombinaciji s nelfinavirom i drugim antivirusnim lijekovima.
Stocrin has been studied in three main studies involving over 1,100 adults:
Stocrin se ispitivao u tri glavna ispitivanja koja su obuhvatila više od 1 100 odraslih osoba:
STOCRIN has not been adequately studied in patients with advanced HIV disease, namely in patients with CD4 counts < 50 cells/mm3, or after failure of protease inhibitor (PI) containing regimens.
STOCRIN nije adekvatno ispitan u bolesnika s uznapredovalom HIV bolešću odnosno u bolesnika s < 50 CD4 stanica/mm3, ili u onih u kojih nije uspjelo liječenje protokolima s inhibitorom proteaze (IP).
STOCRIN has not been adequately studied in patients with advanced HIV disease, namely in patients with CD4 counts < 50 cells/mm3, or after failure of protease inhibitor (PI) containing regimens.
STOCRIN nije adekvatno ispitan u bolesnika s uznapredovalom HIV bolešću, odnosno u bolesnika s < 50 CD4 stanica/mm3, ili u onih u kojih nije uspjelo liječenje protokolima s inhibitorom proteaze (IP).
STOCRIN has not been adequately studied in patients with advanced HIV disease, namely in patients with CD4 counts < 50 cells/mm3, or after failure of protease inhibitor (PI) containing regimens.
STOCRIN nije adekvatno ispitan u bolesnika s uznapredovalom HIV bolešću, odnosno u bolesnika s <50 CD4 stanica/mm3, ili u onih u kojih nije uspjelo liječenje protokolima s inhibitorom proteaze (IP).
Stocrin is a medicine that contains the active substance efavirenz.
Stocrin je lijek koji sadrži djelatnu tvar efavirenz.
Stocrin is also associated with nervous system symptoms, such as dizziness, headache, somnolence (sleepiness), balance disturbances and impaired concentration and with psychiatric disorders, including depression, anxiety, insomnia (difficulty sleeping) and abnormal dreams.
Stocrin se također povezuje sa simptomima živčanog sustava, poput vrtoglavice, glavobolje, somnolencije (pospanosti), poremećaja ravnoteže i narušene koncentracije te psihijatrijskih poremećaja, uključujući depresiju, anksioznost, insomniju (poteškoće sa spavanjem) i abnormalne snove.
Stocrin is an antiviral medicine.
Stocrin je antivirotik.
Stocrin is for oral use.
Stocrin se uzima kroz usta.
Stocrin is not recommended for children under the age of 3 years or weighing less than 13 kg because it has not been adequately studied in these patients
Stocrin se ne preporučuje za djecu mlađu od 3 godine ili djecu tjelesne težine manje od 13 kg jer u tih bolesnika nije ispitan na odgovarajući način.
Stocrin is not recommended for children under the age of 3 years or weighing less than 13 kg because it has not been adequately studied in these patients.
Stocrin se ne preporučuje za djecu mlađu od 3 godine ili djecu tjelesne težine manje od 13 kg jer u tih bolesnika nije ispitan na odgovarajući način
Stocrin is recommended to be taken on an empty stomach prefereably at bedtime.
Preporučuje se uzimati Stocrin na prazan želudac, po mogućnosti prije spavanja.
Stocrin may reduce the amount of itraconazole in your blood. posaconazole.
Stocrin može smanjiti koncentraciju itrakonazola u krvi. posakonazol.
Stocrin may reduce the amount of posaconazole in your blood.
Stocrin može smanjiti koncentraciju posakonazola u krvi.
Stocrin must always be taken in combination with other anti-HIV medicines.
Stocrin se uvijek mora uzimati u kombinaciji s drugim lijekovima protiv HIV-a.
Stocrin must be given in combination with other antiviral medicines.
Stocrin se mora primjenjivati u kombinaciji s drugim antiviroticima.
Stocrin must be taken every day.
Stocrin morate uzimati svaki dan.
Stocrin must be taken with other medicines that act against the HIV virus.
Stocrin se mora uzimati s drugim lijekovima koji djeluju protiv HIV-a.
Stocrin must not be used in patients who are hypersensitive (allergic) to efavirenz or any of the other ingredients.
Stocrin se ne smije primjenjivati u bolesnika koji su preosjetljivi (alergični) na efavirenz ili na bilo koju drugu pomoćnu tvar.
Stocrin oral solution (30 mg/ml) Dose (ml)
Stocrin oralna otopina (30 mg/ml) Doza (ml)
STOCRIN oral solution is indicated in antiviral combination treatment of human immunodeficiency virus-1 (HIV-1) infected adults, adolescents and children 3 years of age and older, who are unable to swallow the hard capsules or the film-coated tablets.
STOCRIN oralna otopina je indicirana u kombiniranom antivirusnom liječenju odraslih, adolescenata i djece u dobi od 3 godine i starije zaraženih virusom humane imunodeficijencije tipa 1 (HIV-1), koji ne mogu gutati tvrde kapsule ili filmom obložene tablete.
Stocrin oral solution may be taken with or without food.
Stocrin oralna otopina može se uzimati s hranom ili bez nje.
Stocrin should never be used alone to treat HIV.
Stocrin nikada ne smijete uzimati kao jedini lijek za liječenje HIV infekcije.
Stomach (abdominal) pain
Bol u trbuhu (abdomenu)
Stomach (abdominal) pain.
Bol u trbuhu (abdominalna bol)
Stomach ache
bol u trbuhu
Stomach ache
Bol u želucu
Stomach ache or bloating
bol u trbuhu ili nadutost
Stomach ache, fast and deep breathing, sleepiness or even loss of consciousness may be signs of a serious condition (ketoacidosis) resulting from lack of insulin.
Bol u trbuhu, brzo i duboko disanje, pospanost ili čak gubitak svijesti mogu biti znakovi teškog stanja (ketoacidoza) koje je nastalo zbog manjka inzulina.
Stomach and bowel disorders which include inflammation of the stomach lining and colon which may cause fever
poremećaji želuca i crijeva koji uključuju upalu želučane sluznice i debelog crijeva, koja može izazvati vrućicu
Stomach and gut: diarrhoea; being sick (vomiting)
Želudac i crijeva: proljev; povraćanje
Stomach and gut: problems digesting food; vomiting blood; vomiting, diarrhoea, and severe right upper corner stomach (abdominal) pain
Želudac i crijeva: poteškoće pri probavljanju hrane; povraćanje krvi; povraćanje; proljev i jaka bol u gornjem desnom dijelu trbuha (abdomena)
Stomach and intestinal (gastrointestinal) problems: Patients taking cysteamine have developed ulcers and bleeding.
Problemi sa želucem i probavom (gastroinstestinalni problemi): Bolesnici koji uzimaju cisteamin su razvili vrijedove i krvarenje.
Stomach and intestinal ulcers and bleeding can occur in patients receiving cysteamine.
Kod bolesnika koji primaju cisteamin mogu se javiti želučani i crijevni vrijedovi te krvarenje.
Stomach discomfort
nelagoda u želucu
Stomach discomfort after meals
Nelagoda u želucu nakon obroka
Stomach pain
bol u trbuhu
Stomach pain
Bol u želucu
Stomach pain
Bolovi u trbuhu
Stomach pain and feeling sick (gastroenteritis).
Bol u želucu i osjećaj mučnine (gastroenteritis).
Stomach pain with feeling sick (nausea).
bol u trbuhu s mučninom
Stomach pain with feeling sick (nausea).
bol u trbuhu s mučninom.
Stomach pain, bloated stomach, feeling sick (nausea), swelling of stoma (an artificial opening for waste removal), vomiting
Bol u trbuhu, nadutost trbuha, mučnina, oticanje stome (umjetnog otvora za pražnjenje stolice), povraćanje
Stomach pain, bloating
bol u želucu, nadutost
Stomach pain, bloating, or diarrhoea, which may be symptoms of inflammation in the large intestine (called colitis or caecitis)
bol u trbuhu, nadutost ili proljev, što mogu biti simptomi upale debelog crijeva (zvane kolitis ili cekitis)
Stomach pain, constipation, indigestion
bolovi u trbuhu, zatvor (konstipacija), probavne tegobe
Stomach pain, diarrhoea, constipation, nausea
bol u želucu, proljev, zatvor, mučnina
Stomach pain, feeling sick
bol u trbuhu, mučnina
Stomach pain, indigestion and flatulence
bol u trbuhu, probavne tegobe i nadimanje,
Stomach pain, indigestion, heartburn
Bol u želucu, probavne tegobe, žgaravica
Stomach pain/heartburn, feeling sick or nauseated
bol u želucu/žgaravica ili mučnina
Stomach pains
bolovi u trbuhu
stomach pains, runny nose and sore throat, ear infection, rash, blood in stool*.
bolovi u trbuhu, curenje nosa i upala grla, infekcija uha, osip, krv u stolici*.
Stomach problems such as feeling sick (nausea) or being sick (vomiting), diarrhoea
Želučani problemi poput osjećaja mučnine ili povraćanja, proljev
Stomach problems such as inflammation or ulcer causing abdominal pain or diarrhoea, bleeding in the stomach, inflammation or ulcer in the mouth, collection of fluid in the belly, vomiting, abdominal pain, indigestion, constipation, passing wind, bloating, loose stools
problemi sa želucem poput upale ili ulkusa koji izazivaju bol u trbuhu ili proljev, krvarenje u želucu, upalu ili ulkus u ustima, nakupljanje tekućine u trbuhu, povraćanje, bol u trbuhu, probavne tegobe, zatvor, vjetrovi, nadutost, mekana stolica
Stomach problems such as inflammation or ulcer causing abdominal pain or diarrhoea, bleeding in the stomach, inflammation or ulcer in the mouth, collection of fluid in the belly, vomiting, abdominal pain, indigestion, constipation, passing wind, bloating, loose stools
želučane tegobe poput upale ili vrijeda koji uzrokuju bol u trbuhu ili proljev, krvarenje u želudac, upala ili vrijed u ustima, nakupljanje tekućine u trbuhu, povraćanje, bol u trbuhu, probavne tegobe, zatvor, vjetrovi, nadutost, mekane stolice
Stomach resistant tablets or capsules (e.g. medicines that reduce stomach acid (proton pump inhibitors)) that should not stay too long in your stomach, may need to be taken an hour before, or four hours after this medicine.
Želučanootporne tablete ili kapsule (npr. lijekovi koji smanjuju kiselinu u želucu (inhibitori protonske pumpe)) koje ne smiju predugo ostati u želucu i možda će ih trebati uzimati jedan sat prije ili četiri sata nakon ovog lijeka.
Stomach Thighs
bedra